Article View: be.science
Article #344Cancer - Press review (December 17, 2011) – Revue de presse (17 décembre 2011)
From: SciMedWeb
Date: Sat, 17 Dec 2011 10:24
Date: Sat, 17 Dec 2011 10:24
158 lines
7873 bytes
7873 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press review (December 17, 2011) – Revue de presse (17 décembre 2011) Christopher Hitchens dies at 62 after suffering cancer He died from pneumonia, a complication of the oesophageal cancer he had, at a Texas hospital. Vanity Fair magazine, which announced his death, said there would "never be another like Christopher". BBC News http://www.bbc.co.uk/news/uk-16212418 HPV tests better than Pap for cervical cancer detection Which cancer screening is best? Amidst a variety of findings this past year, a new study in the Lancet Oncology journal found an HPV test is more effective for detecting cancer in women over 30. Researchers studied more than 45,000 women aged 29 to 56 in the Netherlands, who were given a combination of the pap test and the HPV test, or the Pap test alone. By Maureen Linke. In USA Today http://yourlife.usatoday.com/health/healthyperspective/post/2011-12-15/hpv-tests-better-for-cervial-cancer-detection/586180/1 No brakes on breast cancer cells Scientists of the German Cancer Research Center have discovered a tiny RNA molecule, called miR-520, which at once blocks two important pathways in the development of cancer in cells. In estrogen receptor- negative breast cancer, the production of this microRNA is often reduced and this is correlated with malignant behavior of tumor cells. The DKFZ team has found out that tumors with low levels of miR-520 have a particularly strong tendency to metastasize. PhysOrg.com http://medicalxpress.com/news/2011-12-breast-cancer-cells.html Wonder Woman And Other Comic Book Heroines Featured In African Breast Cancer Awareness Ads The battle against breast cancer just got some super power! Wonder Woman, Cat Woman, Storm and She-Hulk have teamed up to tackle breast cancer awareness for a new ad campaign released in the African nation of Mozambique. By Julee Wilson. In Huffington Post http://www.huffingtonpost.com/2011/12/16/wonder-woman-and-other-co_n_1153758.htmll Cancer Risk Elevated in Myotonic Muscular Dystrophy Patients with myotonic muscular dystrophy (MMD) are at increased risk of developing cancer, particularly of the brain, colon, ovary, and endometrium, a new study suggests. By Megan Brooks. In Medscape http://www.medscape.com/viewarticle/755520 Hologic's cervical cancer device gets FDA nod Medical systems maker Hologic's said U.S. health regulators approved its device to screen for cervical cancer. The company, which makes the ThinPrep cervical cancer test and Selenia digital mammography systems, was granted marketing approval to sell its Cervista High Throughput Automation system. Reuters http://www.reuters.com/article/2011/12/15/hologic-idUSL3E7NF3ZG20111215 Smoking Linked to Skin Cancer in Women Non-melanoma malignancies twice as likely after 20 years of tobacco use, study finds. By Ellin Holohan. In U.S. News & World Report http://health.usnews.com/health-news/family-health/cancer/articles/2011/12/15/smoking-linked-to-skin-cancer-in-women Cancer group aims to boost trust in guidelines In a field plagued by frequent controversy, the American Cancer Society has taken "a major step forward" with a new system for developing trustworthy screening recommendations. By Frederik Joelving. Reuters UK http://uk.reuters.com/article/2011/12/14/us-cancer-group-guidelines-idUKTRE7BD1YI20111214 Plus de 360.000 nouveaux cas de cancers en France en 2011 Quelque 365.000 nouveaux cas de cancers ont été signalés en 2011 dans l'Hexagone, selon les estimations communiquées lors d'un colloque international, organisé dans le cadre du Plan Cancer 2009-2013 par l'Agence de sécurité sanitaire française (Anses) et l'Institut national du cancer (INCa). D'une façon générale, la mortalité par cancer tend à diminuer en France, alors que l'incidence annuelle des cas continue de progresser Dans Le Parisien http://www.leparisien.fr/laparisienne/sante/plus-de-360-000-nouveaux-cas-de-cancers-en-france-en-2011-15-12-2011-1771421.php Jusqu'à quel âge faut-il dépister les cancers ? De plus en plus d'Américains poursuivent les dépistages de cancers après 75 ans. Une tendance également observée en France qui pose la question de l'âge limite. Par Anne Prigent. Dans Le Figaro. http://sante.lefigaro.fr/actualite/2011/12/16/16471-jusqua-quel-age-faut-il-depister-cancers Le gène DCC protège des cancers colorectaux Des chercheurs ont identifié un gène protecteur des cancers colorectaux. Ce gène, appelé DCC, induit un message d'autodestruction des cellules cancéreuses. Des souris génétiquement modifiées, porteuses d'une mutation sur ce gène, ont toutes développé des tumeurs colorectales. Une piste dans la recherche de nouveaux traitements anticancer Dans Futura Sciences http://www.futura-sciences.com/fr/news/t/medecine/d/le-gene-dcc-protege-des-cancers-colorectaux_35261/ Transgene: partenariat avec la Ligue contre le cancer Transgene a conclu avec la Ligue nationale contre le cancer un partenariat visant à accélérer la recherche et le développement de nouvelles biothérapies anticancéreuses. Dans L’Express http://votreargent.lexpress.fr/bourse/fiches-valeurs/transgene-partenariat-avec-la-ligue-contre-le-cancer-depeche_172338.html Contre le cancer, des chercheurs préconisent la pilule pour les religieuses Depuis une semaine, la presse internationale (et française) ne cesse de gloser sur un article publié le 8 décembre dans les colonnes du Lancet , la prestigieuse revue médicale britannique. Dans La Croix http://www.la-croix.com/Religion/Urbi-Orbi/Monde/Contre-le-cancer-des-chercheurs-preconisent-la-pilule-pour-les-religieuses-_NP_-2011-12-13-746707 Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com Marc Lacroix – InTextoResearch – Baelen (12/2011)
Technical Details
Message-ID:
<bb46ee20-1f72-4aba-8ef0-156230f5db88@q16g2000yqn.googlegroups.com>Path:
arc1-ca.pugleaf.net!jh9ni21709bkb.0!nntp.google.com!news1.google.com!postnews.google.com!q16g2000yqn.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: f5500,ace0ab68e93c8937,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.213.28.18 with SMTP id k18mr1085290ebc.7.1324117562557;
Sat, 17 Dec 2011 02:26:02 -0800 (PST)
Path: arc1-ca.pugleaf.net!jh9ni21709bkb.0!nntp.google.com!news1.google.com!postnews.google.com!q16g2000yqn.googlegroups.com!not-for-mail
From: SciMedWeb <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press review (December 17, 2011) – Revue de presse (17 décembre 2011)
Date: Sat, 17 Dec 2011 02:24:29 -0800 (PST)
Organization: http://groups.google.com
Lines: 158
Message-ID: <bb46ee20-1f72-4aba-8ef0-156230f5db88@q16g2000yqn.googlegroups.com>
NNTP-Posting-Host: 81.247.35.229
Mime-Version: 1.0
X-Trace: posting.google.com 1324117562 18572 127.0.0.1 (17 Dec 2011 10:26:02 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 17 Dec 2011 10:26:02 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: q16g2000yqn.googlegroups.com; posting-host=81.247.35.229; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-Google-Web-Client: true
X-Google-Header-Order: UHALERCNK
X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.10.229 Version/11.60,gzip(gfe)
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable